News for Essentra plc (FLRAF)

Revenue: GBP302 million, a 0.3% constant currency increase.Adjusted Operating Profit: GBP40.1 million, a 2.3% constant currency increase.Adjusted Operating Mar

Mar 19, 2025 / 08:30AM GMTScott Fawcett - Essentra PLC - Chief Executive Officer, Executive Director Thank you. So good morning, all. Lovely to see you all toda

Essentra plc reported fiscal 2024 pre-tax profit of 5.7 million pounds compared to 8.4 million pounds, last year. Earnings per share from continuing operations was 4.

Essentra plc issued a trading update for fiscal 2024, ahead of the announcement of its full year results on 19 March 2025. The Group expects to deliver fiscal 2024 adjusted operating profit in line with previous guidance and current analyst expectations.

Revenue Growth: Up 1.5% in constant currency.Operating Profit: Increased by 7.6% in constant currency.Operating Margin: Improved, with a gross margin of 46.4%.

Jul 30, 2024 / 08:00AM GMTScott Fawcett - Essentra PLC - Chief Executive Officer, Executive Director So morning all. Thank you all for joining. So I'm Scott Faw

Essentra shares slumps on revised guidance

Mar 19, 2024 / 09:00AM GMTScott Fawcett - Essentra PLC - CEO Thank you. Good morning, everybody. I'm Scott Fawcett, Chief Exec of Essentra. Delighted to be with

Essentra PLC on Wednesday received approval for its near- and long-term sustainability goals from a UN-backed environmental standards organisation. Essentra is an Oxford, England-based manufacturer...

Global blister packaging market is segmented based on type, technology, material, and end-user. Based on type, the market is segmented into carded, and...

Essentra PLC on Wednesday said that its business was resilient as it performed in line with expectations, as the decline in like-for-like sales revenue decelerated. The Oxford-based components...

The world's leading digital platform for 500,000+ CXOs and business technology executives, named as a top technology conference to attend in 2023 by Tech...

The medicine blister packaging market size in the United States is likely to develop at a 4.00% CAGR through 2034. Changes in retail pharmacy dynamics,...